A Day Up For Aravive, Inc.
Wed, Nov 20, 2019 at 05:30 PM
Aravive, Inc. (ARAV:NASDAQ) shot up today at $9.64, representing a gain of 48.1%. The stock appeared on our News Catalysts scanner on Wed 20 Nov 19 at 09:11 AM. From Wed 30 Oct 19, the stock recorded 71.43% Up Days and 46.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Aravive, Inc. (ARAV:NASDAQ)
Versartis Inc is an endocrine-focused biopharmaceutical company initially developing long-acting recombinant human growth hormone for the treatment of growth hormone deficiency.
Top 10 Gainers:
- Cancer Genetics, Inc. (CGIX:NASDAQ), 131.25%
- Kazia Therapeutics Limited (KZIA:NASDAQ), 105.56%
- Diffusion Pharmaceuticals Inc. (DFFN:NASDAQ), 67.59%
- Aravive, Inc. (ARAV:NASDAQ), 48.08%
- Surface Oncology, Inc. (SURF:NASDAQ), 38.19%
- Cellectar Biosciences, Inc. (CLRB:NASDAQ), 33.05%
- Amira Nature Foods Ltd. (ANFI:NYSE), 29.89%
- Kiniksa Pharmaceuticals, Ltd. (KNSA:NASDAQ), 28.67%
- Zion Oil & Gas, Inc. (ZN:NASDAQ), 25.21%
- NeuBase Therapeutics, Inc. (NBSE:NASDAQ), 25.15%